WBB Securities Reiterates “Strong-Buy” Rating for Cidara Therapeutics (NASDAQ:CDTX)
Cidara Therapeutics (NASDAQ:CDTX – Get Free Report)‘s stock had its “strong-buy” rating reissued by investment analysts at WBB Securities in a report released on Monday,Benzinga reports. They presently have a $45.00 target price on the biotechnology company’s stock. WBB Securities’ price target would indicate a potential downside of 3.93% from the company’s current price. A […]
Cidara Therapeutics (NASDAQ:CDTX – Get Free Report)‘s stock had its “strong-buy” rating reissued by investment analysts at WBB Securities in a report released on Monday,Benzinga reports. They presently have a $45.00 target price on the biotechnology company’s stock. WBB Securities’ price target would indicate a potential downside of 3.93% from the company’s current price. A […]
